安进Amgen Inc. (AMGN) 2020年年度报告「NASDAQ」.pdf

1、2 0 2 0 2020 Letter to Shareholders|AmgenLETTER TO SHAREHOLDERS Robert A.Bradway,Chairman and Chief Executive Officer,Amgen Inc.To My Fellow Shareholders:When I wrote to you one year ago,it was still early days for the COVID-19 pandemic that has since resulted in more than 120 million infections and

2、 2.6 million deaths worldwide.Indeed,2020 proved to be a year like no other,with worldwide economic disruption and social turmoil caused by the greatest public health crisis in more than a century.While the end of the pandemic may not yet be near,we should feel confdent today that we at least have r

3、eached the beginning of the end.Incredible feats of biotechnology have made that possible in a remarkably brief period of time.A belief in the potential of biotechnology inspired Amgens founders to create our company more than 40 years ago.We are even more convinced today about the potential for bio

4、technology to make a positive difference in the world than they were then.Under very trying circumstances,Amgen fulflled many important objectives over the past year.With so many families and companies struggling with the effects of the pandemic,this is not a time to celebrate our performance.Noneth

5、eless,RESPONDING TO COVID-19 I want to acknowledge the resilience of our staff and their dedication to our mission to serve patients.We were strong heading into the pandemic and,Foremost among these is the health and thanks to them,we expect to emerge safety of our employees around thefrom it even s

6、tronger.world.Roughly three-quarters of our staff Throughout 2020,and still today,we have kept our focus on a few priorities.Amgen employees Petra Bjrkander(left)and Mikael Hansson(right)volunteered to help care for severely ill COVID-19 patients at their local hospitals in Sweden,where the pandemic